2 years ago

Automata Technologies Secures $40 Million to Automate Life Sciences Labs

  • London-based automation company for life sciences labs, Automata Technologies, has raised $40 million in funding led by Dimension with participation from A.P

  • Moller Holding, Octopus Ventures, Hummingbird, Isomer Capital, Possible Ventures, and Aldea Ventures

  • The company plans to use the funds to expand its presence across the US, UK, and EMEA

  • Automata's LINQ automation platform provides software for workflow design, proprietary hardware, data accessibility, and an OEM-agnostic approach for integrating diverse labs and equipment

  • The company serves various clients including NHS Trusts, academic institutions, testing labs, CDMOs, CROs, and pharmaceutical and biotech companies.

      • ProblemTechnology

      "Labs are often inefficient, relying on manual processes which are slow, error-prone, and expensive. This leads to bottlenecks and delays in research and development, slowing down the pace of scientific discovery."

      Solution

      "Automata Technologies provides a robotics and automation platform that automates laboratory processes, making them faster, more accurate, and more efficient. This allows scientists to focus on their research, rather than on tedious manual tasks."

      Covered on